BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2187523)

  • 1. Novel screening strategies for early ovarian cancer by transabdominal ultrasonography.
    Campbell S; Royston P; Bhan V; Whitehead MI; Collins WP
    Br J Obstet Gynaecol; 1990 Apr; 97(4):304-11. PubMed ID: 2187523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transabdominal ultrasound screening for early ovarian cancer.
    Campbell S; Bhan V; Royston P; Whitehead MI; Collins WP
    BMJ; 1989 Dec; 299(6712):1363-7. PubMed ID: 2513964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of persistent ovarian masses in asymptomatic women.
    Bhan V; Amso N; Whitehead MI; Campbell S; Royston P; Collins WP
    Br J Obstet Gynaecol; 1989 Dec; 96(12):1384-91. PubMed ID: 2695154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
    Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
    Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer.
    Bourne T; Campbell S; Steer C; Whitehead MI; Collins WP
    BMJ; 1989 Dec; 299(6712):1367-70. PubMed ID: 2513965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound screening for familial ovarian cancer.
    Bourne TH; Whitehead MI; Campbell S; Royston P; Bhan V; Collins WP
    Gynecol Oncol; 1991 Nov; 43(2):92-7. PubMed ID: 1743564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
    Bourne TH; Campbell S; Reynolds KM; Whitehead MI; Hampson J; Royston P; Crayford TJ; Collins WP
    BMJ; 1993 Apr; 306(6884):1025-9. PubMed ID: 8490496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.
    Menon U; Talaat A; Rosenthal AN; Macdonald ND; Jeyerajah AR; Skates SJ; Sibley K; Oram DH; Jacobs IJ
    BJOG; 2014 Dec; 121 Suppl 7():35-9. PubMed ID: 25488086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.
    Jacobs I; Davies AP; Bridges J; Stabile I; Fay T; Lower A; Grudzinskas JG; Oram D
    BMJ; 1993 Apr; 306(6884):1030-4. PubMed ID: 8490497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological impact of screening for familial ovarian cancer.
    Wardle FJ; Collins W; Pernet AL; Whitehead MI; Bourne TH; Campbell S
    J Natl Cancer Inst; 1993 Apr; 85(8):653-7. PubMed ID: 8468723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
    Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transvaginal sonography as a screening method for ovarian cancer.
    Higgins RV; van Nagell JR; Donaldson ES; Gallion HH; Pavlik EJ; Endicott B; Woods CH
    Gynecol Oncol; 1989 Sep; 34(3):402-6. PubMed ID: 2670695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaginal ultrasound as a screening method for detection of adnexa tumors in postmenopause?].
    Osmers R; Völksen M; Rath W; Kuhn W
    Onkologie; 1990 Aug; 13(4):268-70. PubMed ID: 2234779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
    van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaginal sonography: pilot study for using in ovarian screening procedures].
    Duda V; Rode G; Thein C; Schulz KD
    Geburtshilfe Frauenheilkd; 1990 May; 50(5):388-93. PubMed ID: 2197167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
    Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
    Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound.
    Vuento MH; Pirhonen JP; Mäkinen JI; Laippala PJ; Grönroos M; Salmi TA
    Cancer; 1995 Oct; 76(7):1214-8. PubMed ID: 8630900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography.
    Van Nagell JR; DePriest PD; Puls LE; Donaldson ES; Gallion HH; Pavlik EJ; Powell DE; Kryscio RJ
    Cancer; 1991 Aug; 68(3):458-62. PubMed ID: 2065264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
    Hall KL; Dewar MA; Perchalski J
    Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
    van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ
    Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.